{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:56:41Z","timestamp":1770818201897,"version":"3.50.1"},"reference-count":56,"publisher":"Wiley","issue":"1-2","license":[{"start":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T00:00:00Z","timestamp":1264464000000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Informatics"],"published-print":{"date-parts":[[2010,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We examined the relationship between sedation and orthostatic hypotension, two central side effects and ABCB1 transporter\u2010mediated efflux for a set of 64 launched drugs that are documented as histamine H1 receptor antagonists. This relationship was placed in the context of passive diffusion (estimated using Log<jats:italic>P<\/jats:italic>, the octanol\/water partition coefficient), receptor affinity, and the adjusted therapeutic daily dose, in order to account for side effect variability. Within this set, CNS permeability was not dependent on passive diffusion, as no significant differences were found for Log<jats:italic>P<\/jats:italic>and its pH\u2010corrected equivalent, Log<jats:italic>D<\/jats:italic><jats:sub>74<\/jats:sub>. Sedation and orthostatic hypotension can be explained within the framework of ABCB1\u2010mediated efflux and adjusted dose, while target potency has less influence. ABCB1, an antitarget for anticancer agents, acts in fact as a drug target for nonsedating antihistamines. An empirical set of rules, based on the incidence of these two side effects, target affinity and dose was used to predict efflux effects for a number of drugs. Among them, azelastine and mizolastine are predicted to be effluxed via ABCB1\u2010mediated transport, whereas aripiprazole, clozapine, cyproheptadine, iloperidone, olanzapine, and ziprasidone are likely to be noneffluxed.<\/jats:p>","DOI":"10.1002\/minf.200900075","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T15:46:44Z","timestamp":1264520804000},"page":"16-26","source":"Crossref","is-referenced-by-count":31,"title":["Transporter\u2010Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target"],"prefix":"10.1002","volume":"29","author":[{"given":"Fabio","family":"Broccatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Carosati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Cruciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tudor I.","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,26]]},"reference":[{"key":"e_1_2_8_1_2","first-page":"308","volume":"4","author":"Olsson T.","year":"2001","journal-title":"Curr. Opin. Drug Discov. Develop."},{"key":"e_1_2_8_2_2","first-page":"480","volume-title":"Antitargets","year":"2008"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1105511"},{"key":"e_1_2_8_4_2","unstructured":"PubChem is available online at the National Center for Biotechnology Information http:\/\/pubchem.ncbi.nlm.nih.gov\/"},{"key":"e_1_2_8_5_2","unstructured":"Chembldb is available online from the European Bioinformatics Institute http:\/\/www.ebi.ac.uk\/chembldb\/index.php"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2006.12.003"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.24.11515"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(76)90160-7"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90595-7"},{"key":"e_1_2_8_10_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2222.1999.00004.x-i1","author":"Emanuel M. B.","year":"1999","journal-title":"Clin. Exper. Allergy"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90250-4"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1999.0290s3133.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/3527608001.ch21"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1999.00009.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.74.8.597"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244985"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(02)00169-2"},{"key":"e_1_2_8_18_2","author":"Benet L. Z.","year":"2009","journal-title":"Mol. Pharmaceutics"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-3659(95)00147-6"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-5-411"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.06.050"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/10611860108997930"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600760902"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr00020a001"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0928-0987(94)00065-4"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.3.312"},{"key":"e_1_2_8_27_2","first-page":"37","author":"Anonymous","year":"1999","journal-title":"Clin. Exper. Allergy"},{"key":"e_1_2_8_28_2","unstructured":"H. Timmerman 2007 personal communication."},{"key":"e_1_2_8_29_2","unstructured":"The following resources were used to annotate \u2018sedation\u2019 and \u2018orthostatic hypotension\u2019: Clarke\u2019s Analysis of Drugs and Poisons http:\/\/www.medicinescomplete.com\/mc\/clarke\/current\/; DailyMed http:\/\/dailymed.nlm.nih.gov\/dailymed\/about.cfm; Drugs@FDA http:\/\/www.accessdata.fda.gov\/Scripts\/cder\/DrugsatFDA\/; European Medicines Agency http:\/\/www.emea.europa.eu\/htms\/human\/epar\/a.htm; Martindale http:\/\/www.medicinescomplete.com\/mc\/martindale\/current\/; Medicines UK http:\/\/www.medicines.org.uk\/; and the Swedish Pharmacopeia (FASS; in Swedish) http:\/\/www.fass.se\/LIF\/home\/index.jsp. Note: to access Clarke\u2019s and Martindale a subscription license is required."},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/9783527619375.ch13b"},{"key":"e_1_2_8_31_2","unstructured":"The following resources were used to annotate target bioactivity: IUPHAR\u2010DB http:\/\/www.iuphar\u2013db.org\/; PDSP http:\/\/pdsp.med.unc.edu\/pdsp.php; GPCR\u2010DB http:\/\/www.gpcr.org\/7tm\/data\/."},{"key":"e_1_2_8_32_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3565(25)13416-2","volume":"247","author":"Leysen J. E.","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245006"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1995.tb09773.x"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01393-9"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006986824213"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0954-7894.2002.01314.x"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000110300050"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn728"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03632-9"},{"key":"e_1_2_8_41_2","first-page":"33","volume-title":"Conjectures and Refutations","author":"Popper K.","year":"1963"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118699"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/9783527627424.ch10"},{"key":"e_1_2_8_44_2","first-page":"107","volume-title":"Efflux Transporters and the Blood\u2010Brain Barrier","author":"Begley D. J.","year":"2005"},{"key":"e_1_2_8_45_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","volume":"299","author":"Polli J. W.","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.039255"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp0499196"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.017434"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570163043484789"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.092916"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00608215"},{"key":"e_1_2_8_52_2","unstructured":"The FDA label for Xyzal\u00ae (levocetirizine) is available online from the National Library of Medicine http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=7522"},{"key":"e_1_2_8_53_2","unstructured":"S. Boyer 2009 personal communication."},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2009.02.010"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/9783527621460.ch16"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.109156"}],"container-title":["Molecular Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fminf.200900075","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/minf.200900075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:06:11Z","timestamp":1739750771000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/minf.200900075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,12]]},"references-count":56,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,1,12]]}},"alternative-id":["10.1002\/minf.200900075"],"URL":"https:\/\/doi.org\/10.1002\/minf.200900075","archive":["Portico"],"relation":{},"ISSN":["1868-1743","1868-1751"],"issn-type":[{"value":"1868-1743","type":"print"},{"value":"1868-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,12]]}}}